Skip navigation.

GenPhar, Inc.
http://www.genphar.com
Short Header Picture 06

news

categories

For Life

For Future

Publications

Breakthrough Vaccine - Monkeys are completely protected against Dengue Fever by GenPhar's tetravalent Dengue Virus vaccine. 2008-07-17
A tetravalent dengue vaccine based on a complex adenovirus vector provides significant protection in rhesus monkeys against all four serotypes of dengue virus.

J Virol. 2008 Jul;82(14):6927-34. Epub 2008 May 14.
GenPhar develops multivalent vaccine against highly pathogenic H5N1 Avian Influenza and 1918 Spanish Flu. 2008-05-19
Multi-antigen vaccines based on complex adenovirus vectors induce protective immune responses against H5N1 avian influenza viruses.

Vaccine. 2008 May 19;26(21):2627-39. Epub 2008 Mar 14.
Vaccine To Confer to Nonhuman Primates Complete Protection against Multistrain Ebola and Marburg Virus Infections, Clinical and Vaccine Immunology, March 2008 2008-03-05
US Army Medical Research Institute of Infectious Diseases (USAMRIID) publishes the success of the first multivalent Ebola and Marburg virus (pan-filo) vaccine developed with GenPhar, Inc.
Complex Adenovirus-Mediated Expression of West Nile Virus C, PreM, E, and NS1 Proteins Induces both Humoral and Cellular Immune Responses 2007-09-12
Complex Adenovirus-Mediated Expression of West Nile Virus C, PreM, E, and NS1 Proteins Induces both Humoral and Cellular Immune Responses.

Clinical and Vaccine Immunology, 2007 vol. 14 (9) pp. 1117-26
GenPhar's Trivalent Marburg Vaccine Proves 100% Protection, Virology, Fall 2006. 2006-09-26
Early data from GenPhar and USAMRIID's collaboration to develop a trivalent Marburg vaccine published in Virology's September 30, 2006 issue.

Virology 2006 Sep 30;353(2):324-32. Epub 2006 Jul 3.
New data on Bivalent Dengue Virus Vaccine using GenPhar's CAdVax platform is published. 2006-04-06
Induction of bivalent immune response by expression of dengue virus type 1 and type 2 antigens from a single complex adenoviral vector.
GenPhar publishes Trivalent Marburg vaccine study. 2006-04-05
"De novo syntheses of Marburg virus antigens from adenovirus vectors induce potent humoral and cellular immune responses."

Vaccine. 2006 Apr 5;24(15):2975-86. Epub 2005 Dec 9.

GenPhar publishes the first bivalent Ebola vaccine designed to protect against the Sudan and Zaire species 2006-02-26
GenPhar and US Army Ebola vaccine project published in renowned industry magazine.